Cite
HARVARD Citation
Margonis, G. et al. (2019). KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases. HPB. 21 (11), pp. 1527-1534. [Online].